Skip to Main Content

Paper Details

Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling.
Mol Oncol
1
2023
APOBEC, FGFR1, Fibroblast Growth Factor Receptor 1, PARP, PC, Parathyroid carcinoma, Poly(ADP-Ribose), Poly(ADP-Ribose) Polymerase, RET, RNA, Ret Proto-Oncogene, advanced parathyroid carcinoma, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like, lenvatinib, olaparib, patients, receptor tyrosine kinase, tumour, tyrosine, ultra-rare cancers
Author NameAffiliation
Nagarajan Paramasivam
Albrecht StenzingerInstitute of Pathology, Heidelberg University Hospital
Daniel H??bschmann
Daniel H??bschmann
Stefan Fr??hlingNational Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ)
Stefan Fr??hling
  • 1 - 6

Datasets

Release 1.2